NCT02897076View on ClinicalTrials.gov

Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth

PHASE3CompletedINTERVENTIONAL

Enrollment

3,250

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 5, 2020

Study Completion Date

January 5, 2020

Conditions

Neonatal Complications

Interventions

DRUG

betamethasone 24 mg

DRUG

12mg betamethasone +placebo

Trial Locations (1)

75019

Hôpital Robert Debré, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02897076 - Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth | Biotech Hunter | Biotech Hunter